IDSI adds CTLM trial site

By staff writers

November 29, 2007 -- CT laser mammography (CTLM) system developer Imaging Diagnostic Systems (IDSI) of Plantation, FL, has signed the 10th U.S. site to participate in its CTLM clinical trial.

Some sites have begun to collect patient data necessary to submit a Premarket Approval (PMA) application to the U.S. Food and Drug Administration. To date, international clinical sites have performed more than 13,000 CTLM exams, according to the company, but only U.S. data will be used for the PMA application.

The CTLM system uses patented continuous wave laser technology and computer algorithms to create 3D breast images. The system is designed to gather information about blood distribution in the breast to detect angiogenesis, which usually accompanies tumor growth, and the images can be analyzed in tandem with standard mammography, according to the company.

IDSI sells HQ for $4.4 million in leaseback deal, September 19, 2007

IDSI sends CTLM unit to Malaysia, September 5, 2007

Study: IDS' CTLM aids in dense-breast imaging, June 26, 2007

IDSI drops China distributor, April 11, 2007

Hansen re-ups with IDSI, January 23, 2007

Copyright © 2007

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking